PATENT CLAIM ANALYSIS

Application Number: 15877733
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["514", "054000"]

Abstract:
A method for treating diastolic heart failure is provided including identifying a subject having diastolic heart failure and administering a therapeutically effective amount of a galectin-3 inhibitor to the subject to at least partially alleviate a symptom of diastolic heart failure.

Claim (Index 17):
The method of  claim 16 , wherein identifying includes determining that the subject has a left ventricular ejection fraction of greater than about 45%.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 86.0
- Lexical Diversity: 1.4
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14654140', '11996021', '15274533', '15666456', '13229025']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7384783242858123
- 35 USC 102 Novelty (BERT): 0.5326991440218595
- Combined Prediction Score: 0.7179004062594171
- Mean Citation Score: 202.99950000000004
- Max Citation Score: 346.05225
- Similarity Product: 225.961846351862

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test